{
  "_originalData": {
    "identity": {
      "bacteriumName": "Kingella kingae",
      "aliases": [],
      "lastUpdated": "2024-05-28",
      "clsiCategory": "Other Non-Enterobacterales",
      "classification": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacilli",
        "respiration": "Facultative anaerobe",
        "notes": [
          "Member of the HACEK group",
          "Slow-growing and fastidious"
        ]
      },
      "strainDetails": [],
      "biochemicalTests": "Gram-negative coccobacillus, facultative anaerobe, oxidase +, catalase –, ferments glucose, indole –, urease –."
    },
    "clinicalProfile": {
      "summary": "Kingella kingae is a fastidious gram-negative coccobacillus, primarily recognized as a leading cause of septic arthritis and osteomyelitis in young children (6-48 months). It is also a member of the HACEK group, causing culture-negative endocarditis, mainly in adults.",
      "pathophysiologyPearls": [
        "Colonizes the respiratory tract, particularly in young children.",
        "Infection is often preceded by a viral upper respiratory infection, which may damage the respiratory epithelium and facilitate bacterial invasion."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Limp or refusal to bear weight (in septic arthritis/osteomyelitis)",
        "Joint pain, swelling, and decreased range of motion",
        "Symptoms of endocarditis (e.g., new heart murmur, embolic phenomena) in adults"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Septic Arthritis and Osteomyelitis",
          "description": "A leading cause of skeletal infections in children aged 6-48 months."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Can occur, often in young children, and may be occult."
        },
        {
          "syndromeName": "Infective Endocarditis",
          "description": "A rare cause of endocarditis, typically as part of the HACEK group, affecting both native and prosthetic valves."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Children aged 6-48 months"
      ],
      "transmissionVectors": [
        "Endogenous respiratory flora"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Vancomycin",
          "notes": "Predictably resistant."
        },
        {
          "drugOrClass": "Clindamycin",
          "notes": "Predictably resistant."
        },
        {
          "drugOrClass": "Antistaphylococcal Penicillins (Oxacillin, Nafcillin)",
          "notes": "Predictably resistant."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "Susceptible in vitro to cephalosporins, aminoglycosides, TMP-SMX, tetracyclines, and fluoroquinolones.",
        "Cephalosporin therapy is preferred in children."
      ],
      "drugsToAvoid": [
        {
          "drugOrClass": "Tetracyclines",
          "condition": "Treatment in children under 8 years",
          "reason": "Potential for dental staining, though the American Academy of Pediatrics now considers Doxycycline safe for up to 21 days of therapy in children."
        },
        {
          "drugOrClass": "Fluoroquinolones",
          "condition": "Treatment in children under 8 years",
          "reason": "Concerns about cartilage damage, though use may be justified in some situations."
        }
      ],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Empiric",
            "condition": "Haematogenous osteomyelitis in a child not responding to empiric therapy for S. aureus",
            "patientPopulation": [
              "Children"
            ],
            "isolateSource": "Bone/Joint"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Pending culture results",
                  "drugs": [
                    {
                      "drugName": "Cefazolin",
                      "dose": "Varies by age/weight",
                      "route": "IV",
                      "frequency": "Varies",
                      "comments": "Add to existing empiric therapy (e.g., Vancomycin)."
                    },
                    {
                      "drugName": "Ceftriaxone",
                      "dose": "Varies by age/weight",
                      "route": "IV",
                      "frequency": "Varies",
                      "comments": "Add to existing empiric therapy (e.g., Vancomycin)."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Endocarditis",
            "patientPopulation": [
              "Adults"
            ],
            "isolateSource": "Blood"
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "4-6 weeks",
                  "drugs": [
                    {
                      "drugName": "Ceftriaxone",
                      "dose": "2",
                      "route": "IV",
                      "frequency": "daily",
                      "comments": ""
                    },
                    {
                      "drugName": "Gentamicin",
                      "dose": "Low-dose for synergy",
                      "route": "IV",
                      "frequency": "Varies",
                      "comments": "Combination based on theoretical data."
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "4-6 weeks",
                  "drugs": [
                    {
                      "drugName": "Levofloxacin",
                      "dose": "750",
                      "route": "IV/PO",
                      "frequency": "daily",
                      "comments": "For beta-lactam allergic patients. Based on in vitro susceptibility; no clinical data."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        },
        {
          "context": {
            "type": "Directed",
            "condition": "Osteomyelitis/Septic Arthritis",
            "patientPopulation": [
              "Children under 4 years with beta-lactam allergy"
            ],
            "isolateSource": "Bone/Joint"
          },
          "recommendations": [
            {
              "preference": "Alternative",
              "strategy": "Concurrent",
              "steps": [
                {
                  "step": 1,
                  "duration": "Varies",
                  "drugs": [
                    {
                      "drugName": "TMP-SMX",
                      "dose": "Varies by age/weight",
                      "route": "IV/PO",
                      "frequency": "Varies",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Blood cultures, joint aspirates, or bone biopsies are required for diagnosis.",
        "Inoculating specimens into blood culture bottles may enhance recovery."
      ],
      "methodologyNotes": [
        "Kingella kingae is a slow-growing, fastidious organism.",
        "Growth is enhanced on blood or chocolate agar in a CO2-enriched atmosphere."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "",
        "biosafetyWarning": "",
        "methods": []
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": []
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.332Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Kingella kingae"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": []
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2024-05-28"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Gram-negative",
        "morphology": "Coccobacilli",
        "respiration": "Facultative anaerobe",
        "notes": [
          "Member of the HACEK group",
          "Slow-growing and fastidious"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Kingella kingae is a fastidious gram-negative coccobacillus, primarily recognized as a leading cause of septic arthritis and osteomyelitis in young children (6-48 months). It is also a member of the HACEK group, causing culture-negative endocarditis, mainly in adults.",
      "pathophysiologyPearls": [
        "Colonizes the respiratory tract, particularly in young children.",
        "Infection is often preceded by a viral upper respiratory infection, which may damage the respiratory epithelium and facilitate bacterial invasion."
      ],
      "keySignsAndSymptoms": [
        "Fever",
        "Limp or refusal to bear weight (in septic arthritis/osteomyelitis)",
        "Joint pain, swelling, and decreased range of motion",
        "Symptoms of endocarditis (e.g., new heart murmur, embolic phenomena) in adults"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Septic Arthritis and Osteomyelitis",
          "description": "A leading cause of skeletal infections in children aged 6-48 months."
        },
        {
          "syndromeName": "Bacteremia",
          "description": "Can occur, often in young children, and may be occult."
        },
        {
          "syndromeName": "Infective Endocarditis",
          "description": "A rare cause of endocarditis, typically as part of the HACEK group, affecting both native and prosthetic valves."
        }
      ],
      "stagesOfIllness": [],
      "highRiskPopulations": [
        "Children aged 6-48 months"
      ],
      "transmissionVectors": [
        "Endogenous respiratory flora"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [
        {
          "drugOrClass": "Vancomycin",
          "notes": "Predictably resistant."
        },
        {
          "drugOrClass": "Clindamycin",
          "notes": "Predictably resistant."
        },
        {
          "drugOrClass": "Antistaphylococcal Penicillins (Oxacillin, Nafcillin)",
          "notes": "Predictably resistant."
        }
      ],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "empiric",
            "condition": "Haematogenous osteomyelitis in a child not responding to empiric therapy for S. aureus",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children"
              ],
              "labFindings": "Bone/Joint"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Cefazolin",
              "dose": "Varies by age/weight",
              "route": "IV",
              "frequency": "Varies",
              "duration": "Pending culture results",
              "comments": "Add to existing empiric therapy (e.g., Vancomycin).",
              "originalText": "Cefazolin Varies by age/weight IV Varies"
            },
            {
              "drugName": "Ceftriaxone",
              "dose": "Varies by age/weight",
              "route": "IV",
              "frequency": "Varies",
              "duration": "Pending culture results",
              "comments": "Add to existing empiric therapy (e.g., Vancomycin).",
              "originalText": "Ceftriaxone Varies by age/weight IV Varies"
            }
          ]
        },
        {
          "regimenId": "modern-1-0-0",
          "extractedFrom": "treatment.regimens[1].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Endocarditis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Blood"
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Ceftriaxone",
              "dose": "2",
              "route": "IV",
              "frequency": "daily",
              "duration": "4-6 weeks",
              "comments": "",
              "originalText": "Ceftriaxone 2 IV daily"
            },
            {
              "drugName": "Gentamicin",
              "dose": "Low-dose for synergy",
              "route": "IV",
              "frequency": "Varies",
              "duration": "4-6 weeks",
              "comments": "Combination based on theoretical data.",
              "originalText": "Gentamicin Low-dose for synergy IV Varies"
            }
          ]
        },
        {
          "regimenId": "modern-1-1-0",
          "extractedFrom": "treatment.regimens[1].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Endocarditis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Adults"
              ],
              "labFindings": "Blood"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Levofloxacin",
              "dose": "750",
              "route": "IV/PO",
              "frequency": "daily",
              "duration": "4-6 weeks",
              "comments": "For beta-lactam allergic patients. Based on in vitro susceptibility; no clinical data.",
              "originalText": "Levofloxacin 750 IV/PO daily"
            }
          ]
        },
        {
          "regimenId": "modern-2-0-0",
          "extractedFrom": "treatment.regimens[2].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Osteomyelitis/Septic Arthritis",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "Children under 4 years with beta-lactam allergy"
              ],
              "labFindings": "Bone/Joint"
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "TMP-SMX",
              "dose": "Varies by age/weight",
              "route": "IV/PO",
              "frequency": "Varies",
              "duration": "Varies",
              "comments": "",
              "originalText": "TMP-SMX Varies by age/weight IV/PO Varies"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Blood cultures, joint aspirates, or bone biopsies are required for diagnosis.",
        "Inoculating specimens into blood culture bottles may enhance recovery."
      ],
      "methodologyNotes": [
        "Kingella kingae is a slow-growing, fastidious organism.",
        "Growth is enhanced on blood or chocolate agar in a CO2-enriched atmosphere."
      ],
      "recommendedPanel": [],
      "specialTests": [],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}